user

Efficacy and safety of ozanimod in older patients with ulcerative colitis (UC): post hoc analysis of the True North study

被引：0
|
作者：
Chandwe, Kanta [1 ]
Bwakura-Dangarembizi, Mutsa [2 ]
Amadi, Beatrice [1 ]
Tawodzera, Gertrude [2 ]
Murch, Simon [3 ]
Hill, Susan [4 ]
Playford, Ray [5 ,6 ]
VanBuskirk, Kelley [1 ]
Prendergast, Andrew [2 ,7 ]
Kelly, Paul [7 ]
机构：
[1] Univ Zambia, Trop Gastroenterol & Nutr Grp, Lusaka, Zambia
[2] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe
[3] Med Sch, Warw kUnivers, Coventry, England
[4] Great Ormond St Hosp Sick Children, London, England
[5] Univ West London, London, England
[6] Univ Coll Cork, Cork, Ireland
[7] Barts & London Queen Mary Univ London, London, England
来源：
GUT | 2023年 / 72卷 / SUPPL_2期
关键词：
D O I：
10.1136/gutjnl-2023-BSG.172
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P100
引用
收藏
页码：A107 / A107
页数：1
相关论文
共 50 条
  • [1] Ozanimod Efficacy and Safety in Older Patients With Ulcerative Colitis: A Post Hoc Analysis From True North
    Khan, Nabeel
    Irving, Peter
    Blumenstein, Irina
    Horst, Sara
    Ahmad, Harris
    Lawlor, Garrett
    Hobbs, Vanessa
    Jain, Anjali
    Memaj, Arteid
    Ananthakrishnan, Ashwin
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S25 - S25
  • [2] Evaluation of Ozanimod Efficacy and Safety in Older Patients With Ulcerative Colitis: Post Hoc Analysis From the Phase 3 True North Study
    Khan, Nabeel
    Irving, Peter
    Blumenstein, Irina
    Horst, Sara N.
    Ahmad, Harris A.
    Lawlor, Garrett
    Hobbs, Vanessa
    Jain, Anjali
    Memaj, Arteid
    Ananthakrishnan, Ashwin N.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S580 - S581
  • [3] Efficacy of Ozanimod in Vedolizumab-Exposed Patients With Ulcerative Colitis: A Phase 3 True North Post Hoc Analysis
    Sands, Bruce E.
    Jain, Anjali
    Ahmad, Harris A.
    Osterman, Mark
    Memaj, Arteid
    Canavan, James B.
    Axelrad, Jordan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S593 - S594
  • [4] Efficacy of ozanimod in vedolizumab-exposed patients with ulcerative colitis: a phase 3 True North post hoc analysis
    Sands, B. E.
    Jain, A.
    Ahmad, H. A.
    Osterman, M.
    Memaj, A.
    Canavan, J. B.
    Axelrad, J. E.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 507 - 508
  • [5] Efficacy of Ozanimod in Patients With Ulcerative Colitis Who Were Previously Exposed to Vedolizumab: True North Post Hoc Analysis
    Sands, Bruce
    Jain, Anjali
    Harris, Ahmad
    Osterman, Mark
    Memaj, Arteid
    Canavan, James
    Axelrad, Jordan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 : S4 - S4
  • [6] Impact of recent thiopurine use on ozanimod safety in patients with ulcerative colitis: a post hoc analysis of the phase 3 True North study
    Battat, R.
    Panaccione, R.
    Hart, A.
    Hisamatsu, T.
    Ahmad, H. A.
    Osterman, M. T.
    Wu, H.
    Jain, A.
    Rosen, M.
    Siegmund, B.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1100 - I1101
  • [7] Impact of Baseline Disease Duration on Ozanimod Efficacy in Patients With Moderately to Severely Active Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 True North Study
    Lichtenstein, Gary R.
    D'Haens, Geert R.
    Walsh, Alissa
    Glover, Sarah C.
    Lukin, Dana J.
    Cohen, Benjamin L.
    Lawlor, Garrett
    Rosen, Melissa
    Wu, Hsiuanlin
    Osterman, Mark T.
    Jain, Anjali
    Hart, Ailsa
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S960 - S961
  • [8] Ozanimod Is an Effective Oral Treatment for Patients With Ulcerative Colitis Regardless of Baseline Endoscopic Disease Distribution: A Post Hoc Analysis of the Phase 3 True North Study
    Afzali, Anita
    Dignass, Axel
    Fischer, Monika
    Sninsky, Charles
    Armuzzi, Alessandro
    Wu, Chun
    Ahmad, Harris A.
    Memaj, Arteid
    Harris, Sarah
    Canavan, James B.
    Schreiber, Stefan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S513 - S514
  • [9] Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Maintenance in the Phase 3 True North Study
    Kaustav, Shah
    Austin, Triana
    Roman, Gusdorf
    Allison, McCoy
    Baldeep, Pabla
    Elizabeth, Scoville
    Robin, Dalal
    Dawn, Beaulieu
    David, Schwartz
    Michelle, Griffith
    Sara, Horst
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S9 - S9
  • [10] Ozanimod Efficacy, Safety, and Histology in Patients with Moderate-to-Severe Ulcerative Colitis During Induction in the Phase 3 True North Study
    William, Sandborn
    Geert, D'Haens
    Doug, Wolf
    Stephen, Hanauer
    Igor, Jovanovic
    Subrata, Ghosh
    AnnKatrin, Petersen
    Steven, Hua
    Hwan, Lee Ji
    Lorna, Charles
    Keith, Usiskin
    Silvio, Danese
    Brian, Feagan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S6 - S7
12345